As of 2024-12-11, the Relative Valuation of Ramm Pharma Corp (RAMM.CN) is (0.24) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.01 CAD, the upside of Ramm Pharma Corp based on Relative Valuation is -2502.8%.
The range of the Relative Valuation is (0.23) - (0.30) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.6x - 6.0x | 5.7x |
| Forward P/E multiples | 3.2x - 8.1x | 4.0x |
| Fair Price | (0.23) - (0.30) | (0.24) |
| Upside | -2359.2% - -3062.7% | -2502.8% |
| Date | P/E |
| 2024-12-06 | -0.20 |
| 2024-12-02 | -0.30 |
| 2024-11-27 | -0.40 |
| 2024-11-26 | -0.40 |
| 2024-11-25 | -0.40 |
| 2024-11-22 | -0.30 |
| 2024-11-21 | -0.20 |
| 2024-11-19 | -0.20 |
| 2024-11-11 | -0.20 |
| 2024-10-30 | -0.20 |
| 2024-10-24 | -0.20 |
| 2024-10-17 | -0.20 |
| 2024-10-16 | -0.20 |
| 2024-10-07 | -0.30 |
| 2024-09-11 | -0.40 |